Skip to main content

Table 4 Comparison between patients with documented respiratory coinfection versus patients without regarding LOS and laboratory data

From: Respiratory coinfections in COVID-19 patients evaluated by BioFire Pneumonia Panel

Variable Documented respiratory coinfection (n=20) No documented respiratory coinfection (n=20) P-value
LOS 10.05±6.06 9.95±6.77 0.961
TLC (x103/μL) 10.71±5.14 8.07±3.26 0.05
Ferritin* (ng/ml) 992 (266–1730) 595 (334–1241) 0.194§
CRP* (mg/l) 56.3 (15.8–183.9) 54.3 (3.8–122.9) 0.33§
Lymphocytes* (absolute value/μL) 308 (92–486) 337 (288–574) 0.337§
Highest D-dimer* (ng/ml) 313 (690–4985) 221 (458–3487) 0.317§
ALT* (U/L) 59 (34–184) 68 (39–108) 0.73§
AST* U/L 76 (43–129) 42 (38–72) 0.02§
Bilirubin* (mg/dl) 0.6 (0.3–0.9) 0.5 (0.4–0.8) 0.98§
Platelets (x103/μL) 356.8±119.27 328.5±102.38 0.43
Urea* (mg/dl) 66 (51–173) 63 (40.5–132.5) 0.41§
Creatinine* (mg/dl) 1.1 (0.8–1.4) 1 (0.9–1.2) 0.61§
Procalcitonin* (ng/ml) 0.23 (0.07–1.14) 0.05 (0.05–0.31) 0.07§
  1. LOS length of hospital stay, TLC total leukocytic count, CRP C-reactive protein. *Data are represented by median and interquartile range. Data are represented by mean and standard deviation. T test. §Mann-Whitney test